Dr. Patrick Raber is a scientific liaison with Adaptive Biotechnologies, a biotechnology company based in Seattle, Washington that specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Previous to his position at Adaptive, Patrick earned his PhD in the Department of Microbiology, Immunology, at Parasitology at LSU Health Sciences Center New Orleans. Based in Atlanta, Georgia, Patrick serves as scientific expert for applications of Adaptive’s immunosequencing platform including oncology, immunotherapy, transplantation, infectious diseases, and autoimmunity.  Patrick also assists investigators interested in incorporating Adaptive’s technology into clinical trials and research protocols.